112 results on '"Goldman, M."'
Search Results
2. Effects of REM Sleep and systolic blood pressure variability on five-year cardiovascular disease risk
3. Removing the men who have sex with men blood donation deferral: Informing risk models using Canadian public health surveillance data.
4. O21 104-week efficacy and safety of cipaglucosidase alfa+miglustat in patients with late-onset Pompe disease previously treated with alglucosidase alfa
5. The configuration of the fresh–saline groundwater interface within the regional Judea Group carbonate aquifer in northern Israel between the Mediterranean and the Dead Sea base levels as delineated by deep geoelectromagnetic soundings
6. Current distribution of AC surface discharges and associated chemistry
7. FP.17 Long-term follow-up of cipaglucosidase alfa/miglustat in ambulatory patients with Pompe disease: An open-label phase I/II study (ATB200-02)
8. POMPE DISEASE: EP.196 Cipaglucosidase alfa-miglustat versus alglucosidase alfa-placebo in late-onset Pompe disease (LOPD): PROPEL study subgroup analyses
9. Integration of shallow reflection seismics and time domain electromagnetics for detailed study of the coastal aquifer in the Nitzanim area of Israel
10. Characterization of the antiviral activities of eight common carp (Cyprinus carpio) type I interferons.
11. Intranasal midazolam for childhood seizures
12. RATE OF PROGRESSION OF AORTIC STENOSIS IN OLDER PERSONS
13. Induction of thromboses within renal grafts by high-dose prophylactic OKT3
14. 90 Inhalation of colistimethate dry powder (Colobreathe) results in negligible systemic exposure
15. Representation, relaxation and convexity for variational problems in Wiener spaces
16. Selection criteria to protect the blood donor in North America and Europe: past (dogma), present (evidence), and future (hemovigilance)
17. Efficacy and tolerability of once-daily budesonide/formoterol pressurized metered-dose inhaler in adults and adolescents with asthma previously stable with twice-daily budesonide/ formoterol dosing.
18. WS5.5 A randomised, open label phase 3 study to evaluate the efficacy and safety of a dry powder formulation of inhaled colistimethate sodium (Colobreathe®) versus tobramycin nebuliser solution (TNS) in cystic fibrosis subjects with chronic Pseudomonas aeruginosa lung infection
19. The Canadian blood donor health assessment questionnaire: lessons from history, application of cognitive science principles, and recommendations for change.
20. In vitro behavior of silicate glass coatings on Ti6Al4V
21. Anemia and deficiencies of folate and vitamin B-6 are common and vary with season in Chinese women of childbearing age.
22. Improving beta-cell function and identification of diagnosticbiomarkers for treatment monitoring in diabetes
23. Caco-2 cell ferritin formation predicts nonradiolabeled food iron availability in an in vitro digestion/Caco-2 cell culture model.
24. 'Can religious icons be vectors of infectious diseases in hospital settings?'.
25. MT3 OUTCOMES AND HOSPITAL UTILIZATION OF SLEEP APNEA PATIENTS TREATED WITH POSITIVE AIRWAY PRESSURE DURING AND AFTER ONSET OF HEART FAILURE.
26. Measuring prepulse inhibition and facilitation of the eyeblink response to acoustic startle during continuous acquisition with ER-FMRI
27. Amygdala structure and associated neuropsychological function in schizophrenia
28. Impaired hippocampal-mediated glucocorticoid negative feedback in schizophrenia
29. Enhanced hippocampal-mediated HPA response to stress in schizophrenia
30. Influence of iron oxides and calcareous deposits on the hydrogen permeation rate in X65 steel in a simulated groundwater.
31. P220 Association between blood eosinophil count and benralizumab efficacy for adult patients with severe, uncontrolled asthma.
32. P222 Effects of immunoglobulin e concentration, eosinophil concentration, and atopy status on benralizumab efficacy in asthma.
33. P221 Efficacy of benralizumab for patients with severe, uncontrolled atopic asthma by serum immunoglobulin E concentrations.
34. RHD genotyping for prenatal patients with a serologic weak D phenotype.
35. 52. An open study to evaluate the safety and tolerance of Bolus IV Colistin in respiratory exacerbations
36. Effect of Polymorphisms in the Beta2-Adrenergic Receptor Gene (ADRB2) on Response to Long-Acting Beta2-Agonist (LABA) Therapy.
37. Immunotherapy based on dendritic cells: from experimentation to clinical development
38. Improving beta-cell function and identification of diagnostic biomarkers for treatment monitoring in diabetes
39. Effect of Polymorphisms in the ADRB2 3' Untranslated Region (3'UTR) on Response to Inhaled Corticosteroid and Long-Acting β2-Adrenergic Agonist (ICS/LABA) Combination Therapy.
40. Efficacy and Tolerability of Fixed-Dose (FD) and Adjustable-Dose (AD) Budesonide/Formoterol Pressurized Metered-Dose Inhaler (BUD/FM pMDI) and FD Fluticasone Propionate/Salmeterol Dry Powder Inhaler (FP/SAL DPI) Within Racial Groups.
41. Safety of Once-Daily (qd) Budesonide and Formoterol Administered via One Pressurized Metered-Dose Inhaler (pMDI) in Adults and Adolescents With Asthma Previously Stable With Twice-Daily (bid) Budesonide/Formoterol pMDI.
42. Effects on Pulmonary Function of Once-Daily (qd) Budesonide and Formoterol Administered via One Pressurized Metered-Dose Inhaler (pMDI) in Adults and Adolescents With Asthma Previously Stable With Twice-Daily (bid) Budesonide/Formoterol pMDI.
43. Asthma Control with Once-Daily (qd) Budesonide/Formoterol Pressurized Metered-Dose Inhaler (pMDI) in Adults and Adolescents with Asthma Previously Stable with Twice-Daily (bid) Budesonide/Formoterol pMDI.
44. From Tolerance to Autoimmunity: Is There a Risk in Early Life Vaccination?
45. Effect of Gly16Arg β2-Adrenergic Receptor Variation on Response to Formoterol Administered Alone or in Combination With Budesonide in Patients With Moderate to Severe Persistent Asthma.
46. Pain in infants younger than 2 months of age during suprapubic aspiration and transurethral bladder catheterization - a single blind randomized controlled study
47. Ovarian Steroidogenesis and Oocyte Number Is Not Impaired in Women With Mullerian Agenesis: Further Evidence That a Defect in WNT4 Is Not a Common Cause of This Syndrome
48. Information dissemination, market efficiency and the frequency of transactions
49. Application of the integrated NMR-TDEM method in groundwater exploration in Israel
50. A joint application of radiomagnetotellurics and transient electromagnetics to the investigation of a waste deposit in Cologne (Germany)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.